View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Chronic Kidney Disease News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 13, 2023
3 min read
Save

Zanzalintinib a potential ‘novel breakthrough’ in advanced clear cell renal cell carcinoma

Zanzalintinib a potential ‘novel breakthrough’ in advanced clear cell renal cell carcinoma

NASHVILLE, Tenn. — Zanzalintinib monotherapy showed promising antitumor activity among patients with previously treated clear cell renal cell carcinoma, according to findings presented at International Kidney Cancer Symposium: North America.

SPONSORED CONTENT
November 10, 2023
1 min read
Save

Researchers develop all-cause mortality risk prediction model for adults with advanced CKD

Researchers develop all-cause mortality risk prediction model for adults with advanced CKD

PHILADELPHIA — Researchers presented data at ASN Kidney Week from a prediction model that can forecast all-cause mortality in adults with advanced chronic kidney disease.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
November 10, 2023
1 min read
Save

Diabetes linked to poorer survival after nephrectomy for renal cell carcinoma

Diabetes linked to poorer survival after nephrectomy for renal cell carcinoma

NASHVILLE, Tenn. — Diabetes appeared linked to shorter survival among patients who underwent nephrectomy for renal cell carcinoma, according to study results presented at International Kidney Cancer Symposium: North America.

SPONSORED CONTENT
November 09, 2023
2 min read
Save

Study reviews survival timeline in patients who end dialysis

Study reviews survival timeline in patients who end dialysis

PHILADELPHIA — Patients with kidney disease who opted to withdraw from dialysis typically survived around 1 week, according to data presented at ASN Kidney Week.

SPONSORED CONTENT
November 09, 2023
2 min read
Save

After organ donation, kidney stone formers saw fewer cases of nephrolithiasis

After organ donation, kidney stone formers saw fewer cases of nephrolithiasis

PHILADELPHIA — The incidence for a kidney stone event was lower in a cohort of individuals 1 year after donating a kidney compared to individuals who were turned down for donation, data from ASN Kidney Week showed.

SPONSORED CONTENT
November 06, 2023
1 min read
Save

Study: Higher medication nonadherence for Black vs. white adults with glomerular disease

Study: Higher medication nonadherence for Black vs. white adults with glomerular disease

PHILADELPHIA — Black adults with glomerular diseases showed more medication nonadherence compared with white adults, according to study results presented at ASN Kidney Week, here.

SPONSORED CONTENT
November 04, 2023
1 min read
Save

Lower rates of access thrombosis for patients with CKD who receive daprodustat vs. EPO

Lower rates of access thrombosis for patients with CKD who receive daprodustat vs. EPO

PHILADELPHIA — Patients with chronic kidney disease on dialysis who received daprodustat had fewer vascular access thrombosis events compared with patients who had erythropoiesis-stimulating agents, according to data presented here.

SPONSORED CONTENT
November 04, 2023
2 min read
Save

Protection of peer mentorship to reduce hospitalization, ED visits varies by population

Protection of peer mentorship to reduce hospitalization, ED visits varies by population

PHILADELPHIA — The protective effect of peer mentorship to reduce hospitalizations and ED visits in patients on maintenance dialysis may be population-specific, according to a study presented at ASN Kidney Week.

SPONSORED CONTENT
November 03, 2023
8 min watch
Save

VIDEO: Sparsentan well-tolerated, demonstrated sustained anti-proteinuria effects

VIDEO: Sparsentan well-tolerated, demonstrated sustained anti-proteinuria effects

PHILADELPHIA — Sparsentan was shown to be well-tolerated and demonstrated sustained anti-proteinuria effects at the final analysis of 110 weeks, according to research presented at ASN Kidney Week.

SPONSORED CONTENT
November 03, 2023
2 min read
Save

Novel aldosterone synthase inhibitor may aid patients with CKD

Novel aldosterone synthase inhibitor may aid patients with CKD

PHILADELPHIA — A novel aldosterone synthase inhibitor, BI 690517, was well-tolerated and reduced urine albumin-to-creatinine ratio in patients with chronic kidney disease, according to a presentation at ASN Kidney Week.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails